For example, CDK12 is a tumor suppressor in high-grade serous ovarian carcinoma, wherein its recurrent loss-of-function mutations prompt downregulation of HR genes, impairment of DNA double-strand break (DSB) repair via HR and cellular sensitivity to PARP inhibitors (30–32). This evidence concerns the gene CDK12 and ovarian serous carcinoma.